Balancing act: improving safety while retaining efficacy in I-O
Immuno-Oncology Insights 2023; 4(7), 273–277
Published: 8 November
Paolo Antonio Ascierto
Lauren Coyle, Editor, Immuno-Oncology Insights, speaks with Paolo Ascierto, Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Tumor Institute ‘Fondazione G. Pascale’, to discuss development of I-O treatments and emerging strategies, specifically in melanomas, improving the balance safety profiles and treatment-related toxicities.